Literature DB >> 23685109

Intracellularly-retained decorin lacking the C-terminal ear repeat causes ER stress: a cell-based etiological mechanism for congenital stromal corneal dystrophy.

Shoujun Chen1, Mei Sun, Renato V Iozzo, Winston W-Y Kao, David E Birk.   

Abstract

Decorin, a small leucine-rich proteoglycan (SLRP), is involved in the pathophysiology of human congenital stromal corneal dystrophy (CSCD). This disease is characterized by corneal opacities and vision impairment. In reported cases, the human gene encoding decorin contains point mutations in exon 10, generating a truncated form of decorin lacking the C-terminal 33 amino acid residues. We have previously described a transgenic mouse model carrying a similar mutation in the decorin gene that leads to an ocular phenotype characterized by corneal opacities identical to CSCD in humans. We have also identified abnormal synthesis and secretion of various SLRPs in mutant mouse corneas. In the present study, we found that mutant C-terminal truncated decorin was retained in the cytoplasm of mouse keratocytes in vivo and of transfected human embryonic kidney cells. This resulted in endoplasmic reticulum stress and an unfolded protein response. Thus, we propose a novel cell-based mechanism underlying CSCD in which a truncated SLRP protein core is retained intracellularly, its accumulation triggering endoplasmic reticulum stress that results in abnormal SLRP synthesis and secretion, which ultimately affects stromal structure and corneal transparency.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685109      PMCID: PMC3702738          DOI: 10.1016/j.ajpath.2013.04.001

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

Review 1.  The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins.

Authors:  R V Iozzo
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

2.  Proteoglycans in health and disease: emerging concepts and future directions.

Authors:  Renato V Iozzo; Nikos Karamanos
Journal:  FEBS J       Date:  2010-10       Impact factor: 5.542

Review 3.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.

Authors:  R V Iozzo
Journal:  Crit Rev Biochem Mol Biol       Date:  1997       Impact factor: 8.250

4.  Decorin accumulation contributes to the stromal opacities found in congenital stromal corneal dystrophy.

Authors:  Cecilie Bredrup; Espen Stang; Ove Bruland; Barbara P Palka; Robert D Young; Jan Haavik; Per M Knappskog; Eyvind Rødahl
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

5.  A second decorin frame shift mutation in a family with congenital stromal corneal dystrophy.

Authors:  Eyvind Rødahl; Rita Van Ginderdeuren; Per M Knappskog; Cecilie Bredrup; Helge Boman
Journal:  Am J Ophthalmol       Date:  2006-09       Impact factor: 5.258

6.  Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins.

Authors:  L W Fisher; J T Stubbs; M F Young
Journal:  Acta Orthop Scand Suppl       Date:  1995-10

7.  Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene.

Authors:  Cecilie Bredrup; Per M Knappskog; Jacek Majewski; Eyvind Rødahl; Helge Boman
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

8.  Receptor-mediated endocytosis of decorin: involvement of leucine-rich repeat structures.

Authors:  H Hausser; E Schönherr; M Müller; C Liszio; Z Bin; L W Fisher; H Kresse
Journal:  Arch Biochem Biophys       Date:  1998-01-15       Impact factor: 4.013

9.  Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.

Authors:  K G Danielson; H Baribault; D F Holmes; H Graham; K E Kadler; R V Iozzo
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

10.  Amino-terminal deletions in the decorin core protein leads to the biosynthesis of proteoglycans with shorter glycosaminoglycan chains.

Authors:  P Antonsson; J Moses; L A Fransson
Journal:  FEBS Lett       Date:  1996-05-13       Impact factor: 4.124

View more
  13 in total

1.  Decorin differentially modulates the activity of insulin receptor isoform A ligands.

Authors:  Alaide Morcavallo; Simone Buraschi; Shi-Qiong Xu; Antonino Belfiore; Liliana Schaefer; Renato V Iozzo; Andrea Morrione
Journal:  Matrix Biol       Date:  2014-01-02       Impact factor: 11.583

Review 2.  Regulation of corneal stroma extracellular matrix assembly.

Authors:  Shoujun Chen; Michael J Mienaltowski; David E Birk
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

Review 3.  Generation of a multi-functional, target organ-specific, anti-fibrotic molecule by molecular engineering of the extracellular matrix protein, decorin.

Authors:  Tero A H Järvinen; Erkki Ruoslahti
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

Review 4.  Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.

Authors:  Christopher Xie; Dipon K Mondal; Mikdat Ulas; Thomas Neill; Renato V Iozzo
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-16       Impact factor: 4.249

Review 5.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

Review 6.  Characteristics of corneal dystrophies: a review from clinical, histological and genetic perspectives.

Authors:  Ze-Nan Lin; Jie Chen; Hong-Ping Cui
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

Review 7.  Decorin as a multivalent therapeutic agent against cancer.

Authors:  Thomas Neill; Liliana Schaefer; Renato V Iozzo
Journal:  Adv Drug Deliv Rev       Date:  2015-10-30       Impact factor: 15.470

Review 8.  Sequence features, structure, ligand interaction, and diseases in small leucine rich repeat proteoglycans.

Authors:  Norio Matsushima; Hiroki Miyashita; Robert H Kretsinger
Journal:  J Cell Commun Signal       Date:  2021-04-15       Impact factor: 5.782

9.  Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study.

Authors:  Shang-Yi Huang; Hsiu-Hsia Lin; Ming Yao; Jih-Luh Tang; Shang-Ju Wu; Hsin-An Hou; Wen-Chien Chou; Sheng-Chieh Chou; Szu-Chun Hsu; Bor-Sheng Ko; Hsiao-Yun Lu; Woei Tsay; Hwei-Fang Tien
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

10.  Lumican binds ALK5 to promote epithelium wound healing.

Authors:  Osamu Yamanaka; Yong Yuan; Vivien Jane Coulson-Thomas; Tarsis Ferreira Gesteira; Mindy K Call; Yujin Zhang; Jianhua Zhang; Shao-Hsuan Chang; Changchun Xie; Chia-Yang Liu; Shizuya Saika; James V Jester; Winston W-Y Kao
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.